Celltrion gets EMA nod for subcutaneous infliximab biosimilar
Celltrion receives EMA marketing authorisation for Remsima SC, the first subcutaneously-administered option for delivery of infliximab, a treatment for rheumatoid arthritis.
Archives for November 28, 2019
Vaccine priorities drive Altimmune to rethink pipeline
Altimmune cites changing priorities of governments and manufacturers to explain shift in vaccine strategy.
Australia proposes manufacturing standards for faecal transplant products
Australia’s TGA proposes manufacturing standards to ensure the safe production of faecal microbiota transplant products.
Thermo Fisher expands site, boosts biologics processing offering
Thermo Fisher Scientific doubles the capacity of its gene therapy and viral vector processing facility in Alachua, Florida, to provide scalability to customers.